Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.

Krysan K, Kusko R, Grogan T, O'Hearn J, Reckamp KL, Walser TC, Garon EB, Lenburg ME, Sharma S, Spira AE, Elashoff D, Dubinett SM.

Mol Cancer Res. 2014 May;12(5):765-74. doi: 10.1158/1541-7786.MCR-13-0377. Epub 2014 Jan 27.

PMID:
24469837
[PubMed - in process]
2.

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.

Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A, Hu J.

J Exp Clin Cancer Res. 2010 Nov 22;29:151. doi: 10.1186/1756-9966-29-151.

PMID:
21092188
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

PMID:
22583478
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.

Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J.

Cancer Lett. 2011 Oct 1;309(1):62-70. doi: 10.1016/j.canlet.2011.05.017. Epub 2011 Jun 12.

PMID:
21664042
[PubMed - indexed for MEDLINE]
5.

miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.

Abe W, Nasu K, Nakada C, Kawano Y, Moriyama M, Narahara H.

Hum Reprod. 2013 Mar;28(3):750-61. doi: 10.1093/humrep/des446. Epub 2013 Jan 4.

PMID:
23293219
[PubMed - indexed for MEDLINE]
Free Article
6.

MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ.

J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35.

PMID:
21270667
[PubMed - indexed for MEDLINE]
7.

A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis.

Olive V, Sabio E, Bennett MJ, De Jong CS, Biton A, McGann JC, Greaney SK, Sodir NM, Zhou AY, Balakrishnan A, Foth M, Luftig MA, Goga A, Speed TP, Xuan Z, Evan GI, Wan Y, Minella AC, He L.

Elife. 2013 Oct 15;2:e00822. doi: 10.7554/eLife.00822.

PMID:
24137534
[PubMed]
Free PMC Article
8.

miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.

Cai J, Fang L, Huang Y, Li R, Yuan J, Yang Y, Zhu X, Chen B, Wu J, Li M.

Cancer Res. 2013 Sep 1;73(17):5402-15. doi: 10.1158/0008-5472.CAN-13-0297. Epub 2013 Jul 15.

PMID:
23856247
[PubMed - indexed for MEDLINE]
9.

Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis.

Xiang J, Wu J.

Curr Genomics. 2010 Apr;11(2):129-35. doi: 10.2174/138920210790886853.

PMID:
20885820
[PubMed]
Free PMC Article
10.

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW.

Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26.

PMID:
20978205
[PubMed - indexed for MEDLINE]
Free Article
11.

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.

Bandi N, Vassella E.

Mol Cancer. 2011 May 16;10:55. doi: 10.1186/1476-4598-10-55.

PMID:
21575235
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
[PubMed - indexed for MEDLINE]
13.

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.

Catuogno S, Cerchia L, Romano G, Pognonec P, Condorelli G, de Franciscis V.

Oncogene. 2013 Jan 17;32(3):341-51. doi: 10.1038/onc.2012.51. Epub 2012 Feb 27.

PMID:
22370637
[PubMed - indexed for MEDLINE]
14.

Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

Xiong J, Du Q, Liang Z.

Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241. Epub 2010 Jun 21.

PMID:
20562918
[PubMed - indexed for MEDLINE]
15.

MiR-449c targets c-Myc and inhibits NSCLC cell progression.

Miao LJ, Huang SF, Sun ZT, Gao ZY, Zhang RX, Liu Y, Wang J.

FEBS Lett. 2013 May 2;587(9):1359-65. doi: 10.1016/j.febslet.2013.03.006. Epub 2013 Mar 15.

PMID:
23507140
[PubMed - indexed for MEDLINE]
Free Article
16.

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB.

Oncogene. 2011 Jun 9;30(23):2644-58. doi: 10.1038/onc.2010.642. Epub 2011 Feb 28.

PMID:
21358675
[PubMed - indexed for MEDLINE]
17.

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

Liu ZL, Wang H, Liu J, Wang ZX.

Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.

PMID:
22956424
[PubMed - indexed for MEDLINE]
18.

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.

Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, Long X, Jiang Q, Song Y, Cheng C, Wang H, Zhao M, Fu Q, Lyu X, Chen Y, Fan Y, Liu Y, Li X, Fang W.

Cell Death Dis. 2013 Oct 24;4:e872. doi: 10.1038/cddis.2013.376.

PMID:
24157866
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.

Gao Y, Fan X, Li W, Ping W, Deng Y, Fu X.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):179-86. doi: 10.1016/j.bbrc.2014.02.073. Epub 2014 Feb 28.

PMID:
24582749
[PubMed - indexed for MEDLINE]
20.

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT.

Wu DW, Hsu NY, Wang YC, Lee MC, Cheng YW, Chen CY, Lee H.

Oncogene. 2014 Jun 9;0. doi: 10.1038/onc.2014.152. [Epub ahead of print]

PMID:
24909176
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk